欧扎克银行 OZK 深 沪
等待开盘 04-02 09:30:00 美东时间
46.17
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 46.17
- 总市值 50.96亿
- 52周最高 52.75
- 市盈率 静 7.48
- 换手率 0.00%
- 52周最低 36.32
- 委 比 0.00%
- 总股本 1.10亿
- 历史最高 52.75
- 量 比 0
- 振 幅 0.00%
- 历史最低 5.79
- 每 手 1
- 风险率 3.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Bank OZK 4.625% PER PFD A declares $0.289 dividend
Bank OZK 4.625% PER PFD A (OZKAP) declares $0.289/share quarterly dividend. Forward yield 7.25% Payable May 15; for shareholders of record May 1; ex-div May 1. See OZKAP Dividend Scorecard, Yield Char...
今天 04:05
Bank OZK raises quarterly dividend by 2.2% to $0.47/share
Bank OZK (OZK) declares $0.47/share quarterly dividend, 2.2% increase from prior dividend of $0.46. Forward yield 4.07% Payable April 20; for shareholders of record April 13; ex-div April 13. See OZK ...
今天 04:03
Bank OZK Announces Increase to Quarterly Common Stock Dividend and Announces Preferred Stock Dividend
Bank OZK announced a quarterly cash dividend increase of $0.01, or 2.17%, on its common stock, marking the 63rd consecutive quarter of dividend growth. The dividend of $0.47 per share is payable on April 20, 2026, to shareholders of record as of April 13, 2026. Additionally, a $0.28906 per share dividend on its Series A Preferred Stock is payable on May 15, 2026. The bank has been included in the S&P High Yield Dividend Aristocrats® index since J...
04-01 20:01
美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
Wells Fargo Maintains Equal-Weight on Bank OZK, Raises Price Target to $50
Wells Fargo analyst Robert Rutschow maintains Bank OZK (NASDAQ:OZK) with a Equal-Weight and raises the price target from $48 to $50.
03-30 22:36
新浪财经ESG：欧扎克银行 MSCI（明晟）ESG评级调降至BB
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:14
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
Shares of banking companies are trading lower as the industry faces potential losses related to the collapse of Market Financial Solutions. January PPI figures, concerns about AI disruption in consumer lending and Nvidia's Q1 results may also contribute to weakness.
Shares of banking companies are trading lower as the industry faces potential l...
02-28 02:16
Shares of banking and financial services companies are trading higher alongside the overall market strength.
Shares of banking and financial services companies are trading higher alongside...
02-07 04:54
美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元
今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元
01-23 19:46
